Hormonal Hair Loss

Hormonal hair loss, or androgenic alopecia, is a common condition that occurs when shifts in hormone levels disrupt the hair growth cycle.

 Increased sensitivity to androgens—such as testosterone and dihydrotestosterone (DHT)—can cause hair follicles to gradually shrink, producing finer, shorter hairs over time. In men, this typically presents as a receding hairline or thinning on the crown. In women, it often appears as diffuse thinning across the scalp, particularly during perimenopause, menopause, after pregnancy, or when hormonal conditions like PCOS or thyroid disorders are present. A range of treatment options exist, including therapies that reduce androgen effects on the follicle, topical formulations targeting hormonal pathways, and supportive lifestyle measures to optimise overall hair health.
 
A treatment is now available developed by one of our Endocrinologists. Hairevive was founded on the belief that everyone deserves to feel confident and comfortable in their own hair. We understand the emotional impact of hair loss, which is why our approach centers on care, understanding, and real, scientific solutions.
Our products are formulated using the latest clinical research and are specifically designed to target hormonal hair thinning.  The formulas are the result of years of research and clinical experience of our founder A/Prof Torkamani who is a leading Endocrinologist with a specialised focus on understanding—and treating—the hormonal drivers of hair loss.
 
With deep expertise in endocrine physiology, she has spent years exploring how shifts in hormones such as androgens, thyroid hormones, and stress hormones can disrupt the hair cycle, weaken follicles, and trigger progressive thinning in both women and men.
 
Her passion for advancing this field began during her PhD and post-fellowship research at the University of Melbourne, where she conducted one of the most prominent Australian studies examining the hormonal mechanisms behind androgenic alopecia. Her work investigated how hormonal imbalances affect follicular miniaturisation and scalp health, and contributed valuable insights into personalised, hormone-targeted treatment strategies. This research has been published in respected scientific journals, including the British Journal of Dermatology, and continues to inform best-practice care in clinical endocrinology.